Praxis Home Retail Limited
Praxis Home Retail Limited (PRAXIS.BO) Stock Competitors & Peer Comparison
See (PRAXIS.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Specialty Retail Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PRAXIS.BO | ₹7.90 | -2.11% | 1.5B | 3.91 | ₹2.02 | N/A |
| ETERNAL.BO | ₹254.05 | +0.10% | 2.3T | 1104.57 | ₹0.23 | N/A |
| ZOMATO.NS | ₹215.19 | +0.00% | 2T | 286.92 | ₹0.75 | N/A |
| ZOMATO.BO | ₹215.25 | +0.00% | 2T | 377.63 | ₹0.57 | N/A |
| MEESHO.NS | ₹172.68 | -3.45% | 788.1B | -30.14 | -₹5.73 | N/A |
| NYKAA.BO | ₹267.95 | -0.91% | 767.2B | 535.90 | ₹0.50 | N/A |
| NYKAA.NS | ₹267.85 | -0.84% | 766.9B | 546.63 | ₹0.49 | N/A |
| SWIGGY.BO | ₹275.25 | -2.25% | 714.7B | -14.78 | -₹18.62 | N/A |
| SWIGGY.NS | ₹275.00 | -2.59% | 714B | -14.76 | -₹18.63 | N/A |
| REDTAPE.NS | ₹130.18 | +0.19% | 72B | 33.90 | ₹3.84 | +0.58% |
Stock Comparison
PRAXIS.BO vs ETERNAL.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ETERNAL.BO has a market cap of 2.3T. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while ETERNAL.BO trades at ₹254.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ETERNAL.BO's P/E ratio is 1104.57. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ETERNAL.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ETERNAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ETERNAL.BO's competition here
PRAXIS.BO vs ZOMATO.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ZOMATO.NS has a market cap of 2T. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while ZOMATO.NS trades at ₹215.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ZOMATO.NS's P/E ratio is 286.92. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ZOMATO.NS's ROE of +0.02%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ZOMATO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ZOMATO.NS's competition here
PRAXIS.BO vs ZOMATO.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ZOMATO.BO has a market cap of 2T. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while ZOMATO.BO trades at ₹215.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ZOMATO.BO's P/E ratio is 377.63. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ZOMATO.BO's ROE of +0.00%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ZOMATO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ZOMATO.BO's competition here
PRAXIS.BO vs MEESHO.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, MEESHO.NS has a market cap of 788.1B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while MEESHO.NS trades at ₹172.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas MEESHO.NS's P/E ratio is -30.14. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to MEESHO.NS's ROE of N/A. Regarding short-term risk, PRAXIS.BO is more volatile compared to MEESHO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check MEESHO.NS's competition here
PRAXIS.BO vs NYKAA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, NYKAA.BO has a market cap of 767.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while NYKAA.BO trades at ₹267.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas NYKAA.BO's P/E ratio is 535.90. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to NYKAA.BO's ROE of +0.11%. Regarding short-term risk, PRAXIS.BO is more volatile compared to NYKAA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check NYKAA.BO's competition here
PRAXIS.BO vs NYKAA.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, NYKAA.NS has a market cap of 766.9B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while NYKAA.NS trades at ₹267.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas NYKAA.NS's P/E ratio is 546.63. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to NYKAA.NS's ROE of +0.11%. Regarding short-term risk, PRAXIS.BO is more volatile compared to NYKAA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check NYKAA.NS's competition here
PRAXIS.BO vs SWIGGY.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, SWIGGY.BO has a market cap of 714.7B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while SWIGGY.BO trades at ₹275.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas SWIGGY.BO's P/E ratio is -14.78. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to SWIGGY.BO's ROE of -0.48%. Regarding short-term risk, PRAXIS.BO is more volatile compared to SWIGGY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check SWIGGY.BO's competition here
PRAXIS.BO vs SWIGGY.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, SWIGGY.NS has a market cap of 714B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while SWIGGY.NS trades at ₹275.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas SWIGGY.NS's P/E ratio is -14.76. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to SWIGGY.NS's ROE of -0.48%. Regarding short-term risk, PRAXIS.BO is more volatile compared to SWIGGY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check SWIGGY.NS's competition here
PRAXIS.BO vs REDTAPE.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, REDTAPE.NS has a market cap of 72B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while REDTAPE.NS trades at ₹130.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas REDTAPE.NS's P/E ratio is 33.90. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to REDTAPE.NS's ROE of +0.27%. Regarding short-term risk, PRAXIS.BO is more volatile compared to REDTAPE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check REDTAPE.NS's competition here
PRAXIS.BO vs AVL.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, AVL.NS has a market cap of 69.1B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while AVL.NS trades at ₹534.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas AVL.NS's P/E ratio is 62.42. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to AVL.NS's ROE of +0.18%. Regarding short-term risk, PRAXIS.BO is more volatile compared to AVL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check AVL.NS's competition here
PRAXIS.BO vs RTNINDIA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, RTNINDIA.BO has a market cap of 49.5B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while RTNINDIA.BO trades at ₹35.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas RTNINDIA.BO's P/E ratio is -12.03. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to RTNINDIA.BO's ROE of -0.38%. Regarding short-term risk, PRAXIS.BO is more volatile compared to RTNINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check RTNINDIA.BO's competition here
PRAXIS.BO vs EMIL.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, EMIL.BO has a market cap of 48.9B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while EMIL.BO trades at ₹127.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas EMIL.BO's P/E ratio is 52.34. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to EMIL.BO's ROE of +0.06%. Regarding short-term risk, PRAXIS.BO is more volatile compared to EMIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check EMIL.BO's competition here
PRAXIS.BO vs EMIL.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, EMIL.NS has a market cap of 48.9B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while EMIL.NS trades at ₹127.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas EMIL.NS's P/E ratio is 52.33. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to EMIL.NS's ROE of +0.06%. Regarding short-term risk, PRAXIS.BO is more volatile compared to EMIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check EMIL.NS's competition here
PRAXIS.BO vs GARGI.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, GARGI.BO has a market cap of 10B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while GARGI.BO trades at ₹950.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas GARGI.BO's P/E ratio is 32.75. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to GARGI.BO's ROE of +0.29%. Regarding short-term risk, PRAXIS.BO is less volatile compared to GARGI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check GARGI.BO's competition here
PRAXIS.BO vs DENTALKART.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, DENTALKART.NS has a market cap of 7.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while DENTALKART.NS trades at ₹449.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas DENTALKART.NS's P/E ratio is 42.92. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to DENTALKART.NS's ROE of N/A. Regarding short-term risk, PRAXIS.BO is less volatile compared to DENTALKART.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check DENTALKART.NS's competition here
PRAXIS.BO vs LOGICA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, LOGICA.BO has a market cap of 3.6B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while LOGICA.BO trades at ₹204.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas LOGICA.BO's P/E ratio is 26.07. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to LOGICA.BO's ROE of N/A. Regarding short-term risk, PRAXIS.BO is less volatile compared to LOGICA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check LOGICA.BO's competition here
PRAXIS.BO vs PANORAMA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, PANORAMA.BO has a market cap of 3.1B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while PANORAMA.BO trades at ₹41.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas PANORAMA.BO's P/E ratio is 27.86. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to PANORAMA.BO's ROE of +0.18%. Regarding short-term risk, PRAXIS.BO is more volatile compared to PANORAMA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check PANORAMA.BO's competition here
PRAXIS.BO vs KDML.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, KDML.BO has a market cap of 3.1B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while KDML.BO trades at ₹132.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas KDML.BO's P/E ratio is 15.75. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to KDML.BO's ROE of +0.16%. Regarding short-term risk, PRAXIS.BO is more volatile compared to KDML.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check KDML.BO's competition here
PRAXIS.BO vs LLOYDS.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, LLOYDS.NS has a market cap of 2.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while LLOYDS.NS trades at ₹95.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas LLOYDS.NS's P/E ratio is -3.35. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to LLOYDS.NS's ROE of N/A. Regarding short-term risk, PRAXIS.BO is more volatile compared to LLOYDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check LLOYDS.NS's competition here
PRAXIS.BO vs COMPEAU.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, COMPEAU.BO has a market cap of 2.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while COMPEAU.BO trades at ₹361.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas COMPEAU.BO's P/E ratio is 11.49. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to COMPEAU.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS.BO is more volatile compared to COMPEAU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check COMPEAU.BO's competition here
PRAXIS.BO vs AAYUSH.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, AAYUSH.BO has a market cap of 1.9B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while AAYUSH.BO trades at ₹39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas AAYUSH.BO's P/E ratio is 42.39. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to AAYUSH.BO's ROE of +0.54%. Regarding short-term risk, PRAXIS.BO is more volatile compared to AAYUSH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check AAYUSH.BO's competition here
PRAXIS.BO vs PRAXIS.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, PRAXIS.NS has a market cap of 1.5B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while PRAXIS.NS trades at ₹7.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas PRAXIS.NS's P/E ratio is 3.92. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to PRAXIS.NS's ROE of -1.13%. Regarding short-term risk, PRAXIS.BO is more volatile compared to PRAXIS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check PRAXIS.NS's competition here
PRAXIS.BO vs KEMP.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, KEMP.BO has a market cap of 1.3B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while KEMP.BO trades at ₹1,159.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas KEMP.BO's P/E ratio is -79.53. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to KEMP.BO's ROE of -0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to KEMP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check KEMP.BO's competition here
PRAXIS.BO vs ISFT.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ISFT.NS has a market cap of 1.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while ISFT.NS trades at ₹73.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ISFT.NS's P/E ratio is 9.57. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ISFT.NS's ROE of +0.05%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ISFT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ISFT.NS's competition here
PRAXIS.BO vs ISFT.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ISFT.BO has a market cap of 1.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while ISFT.BO trades at ₹73.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ISFT.BO's P/E ratio is 9.54. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ISFT.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ISFT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ISFT.BO's competition here
PRAXIS.BO vs WOMANCART.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, WOMANCART.NS has a market cap of 1.1B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while WOMANCART.NS trades at ₹150.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas WOMANCART.NS's P/E ratio is 10.70. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to WOMANCART.NS's ROE of N/A. Regarding short-term risk, PRAXIS.BO is less volatile compared to WOMANCART.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check WOMANCART.NS's competition here
PRAXIS.BO vs DIGIDRIVE.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, DIGIDRIVE.NS has a market cap of 921.3M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while DIGIDRIVE.NS trades at ₹23.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas DIGIDRIVE.NS's P/E ratio is 7.41. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to DIGIDRIVE.NS's ROE of +0.04%. Regarding short-term risk, PRAXIS.BO is more volatile compared to DIGIDRIVE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check DIGIDRIVE.NS's competition here
PRAXIS.BO vs ARCHIES.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ARCHIES.NS has a market cap of 495.9M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while ARCHIES.NS trades at ₹14.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ARCHIES.NS's P/E ratio is -44.48. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ARCHIES.NS's ROE of -0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ARCHIES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ARCHIES.NS's competition here
PRAXIS.BO vs ARCHIES.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ARCHIES.BO has a market cap of 490.8M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while ARCHIES.BO trades at ₹14.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ARCHIES.BO's P/E ratio is -46.87. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ARCHIES.BO's ROE of -0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ARCHIES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ARCHIES.BO's competition here
PRAXIS.BO vs PACE.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, PACE.BO has a market cap of 394.8M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while PACE.BO trades at ₹17.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas PACE.BO's P/E ratio is 9.63. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to PACE.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS.BO is more volatile compared to PACE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check PACE.BO's competition here
PRAXIS.BO vs DUKEOFS.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, DUKEOFS.BO has a market cap of 177.4M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while DUKEOFS.BO trades at ₹18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas DUKEOFS.BO's P/E ratio is -31.58. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to DUKEOFS.BO's ROE of -0.12%. Regarding short-term risk, PRAXIS.BO is more volatile compared to DUKEOFS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check DUKEOFS.BO's competition here
PRAXIS.BO vs UHZAVERI.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, UHZAVERI.BO has a market cap of 148M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while UHZAVERI.BO trades at ₹14.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas UHZAVERI.BO's P/E ratio is -371.25. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to UHZAVERI.BO's ROE of +0.00%. Regarding short-term risk, PRAXIS.BO is more volatile compared to UHZAVERI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check UHZAVERI.BO's competition here
PRAXIS.BO vs DARSHANORNA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, DARSHANORNA.BO has a market cap of 122.3M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while DARSHANORNA.BO trades at ₹2.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas DARSHANORNA.BO's P/E ratio is 50.60. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to DARSHANORNA.BO's ROE of +0.03%. Regarding short-term risk, PRAXIS.BO is more volatile compared to DARSHANORNA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check DARSHANORNA.BO's competition here
PRAXIS.BO vs RAJPUTANA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, RAJPUTANA.BO has a market cap of 105.6M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while RAJPUTANA.BO trades at ₹34.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas RAJPUTANA.BO's P/E ratio is 85.73. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to RAJPUTANA.BO's ROE of +0.03%. Regarding short-term risk, PRAXIS.BO is more volatile compared to RAJPUTANA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check RAJPUTANA.BO's competition here
PRAXIS.BO vs DDIL.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, DDIL.BO has a market cap of 95.1M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while DDIL.BO trades at ₹1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas DDIL.BO's P/E ratio is 4.42. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to DDIL.BO's ROE of +0.26%. Regarding short-term risk, PRAXIS.BO is more volatile compared to DDIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check DDIL.BO's competition here
PRAXIS.BO vs VEERKRUPA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, VEERKRUPA.BO has a market cap of 87.8M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while VEERKRUPA.BO trades at ₹0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas VEERKRUPA.BO's P/E ratio is 33.50. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to VEERKRUPA.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to VEERKRUPA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check VEERKRUPA.BO's competition here
PRAXIS.BO vs HARIAEXPO.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, HARIAEXPO.BO has a market cap of 70.3M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while HARIAEXPO.BO trades at ₹6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas HARIAEXPO.BO's P/E ratio is 50.75. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to HARIAEXPO.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.BO is less volatile compared to HARIAEXPO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check HARIAEXPO.BO's competition here
PRAXIS.BO vs MHSGRMS.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, MHSGRMS.BO has a market cap of 41.2M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while MHSGRMS.BO trades at ₹5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas MHSGRMS.BO's P/E ratio is 6.09. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to MHSGRMS.BO's ROE of -2.86%. Regarding short-term risk, PRAXIS.BO is more volatile compared to MHSGRMS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check MHSGRMS.BO's competition here
PRAXIS.BO vs JSHL.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, JSHL.BO has a market cap of 40M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while JSHL.BO trades at ₹6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas JSHL.BO's P/E ratio is -9.06. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to JSHL.BO's ROE of -0.02%. Regarding short-term risk, PRAXIS.BO is more volatile compared to JSHL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check JSHL.BO's competition here
PRAXIS.BO vs SPECTRA.BO Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, SPECTRA.BO has a market cap of 36.1M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while SPECTRA.BO trades at ₹5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas SPECTRA.BO's P/E ratio is -1.44. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to SPECTRA.BO's ROE of +0.07%. Regarding short-term risk, PRAXIS.BO is more volatile compared to SPECTRA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check SPECTRA.BO's competition here
PRAXIS.BO vs PRAXIS-RE.NS Comparison April 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, PRAXIS-RE.NS has a market cap of 0. Regarding current trading prices, PRAXIS.BO is priced at ₹7.90, while PRAXIS-RE.NS trades at ₹15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas PRAXIS-RE.NS's P/E ratio is N/A. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to PRAXIS-RE.NS's ROE of N/A. Regarding short-term risk, PRAXIS.BO is less volatile compared to PRAXIS-RE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check PRAXIS-RE.NS's competition here